Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Betahistine effects on weight-related measures in patients treated with antipsychotic medications: a double-blind placebo-controlled study
Authors
Keywords
-
Journal
PSYCHOPHARMACOLOGY
Volume 235, Issue 12, Pages 3545-3558
Publisher
Springer Nature America, Inc
Online
2018-11-01
DOI
10.1007/s00213-018-5079-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors and Moderators of Antipsychotic-Related Weight Gain in the Treatment of Early-Onset Schizophrenia Spectrum Disorders Study
- (2018) Jerome H. Taylor et al. JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY
- A Randomized, Double-Blind, Placebo-Controlled Pilot Study of Betahistine to Counteract Olanzapine-Associated Weight Gain
- (2016) Nir Barak et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Betahistine decreases olanzapine-induced weight gain and somnolence in humans
- (2016) Nir Barak et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Ameliorating antipsychotic-induced weight gain by betahistine: Mechanisms and clinical implications
- (2016) Jiamei Lian et al. PHARMACOLOGICAL RESEARCH
- Chronic betahistine co-treatment reverses olanzapine's effects on dopamine D2 but not 5-HT2A/2C bindings in rat brains
- (2015) Jiamei Lian et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Weight gain and antipsychotics: a drug safety review
- (2014) Richard Musil et al. Expert Opinion On Drug Safety
- Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model
- (2012) Chao Deng et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine–betahistine combination
- (2012) Michael Poyurovsky et al. PSYCHOPHARMACOLOGY
- Atypical Antipsychotic-Induced Weight Gain
- (2011) James L. Roerig et al. CNS DRUGS
- Involvement of histamine receptors in the atypical antipsychotic profile of clozapine: a reassessment in vitro and in vivo
- (2011) Marie Humbert-Claude et al. PSYCHOPHARMACOLOGY
- Acute effects of betahistine hydrochloride on food intake and appetite in obese women: a randomized, placebo-controlled trial
- (2010) Asem H Ali et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Adjunctive Risperidone for Partially Responsive People with Schizophrenia Treated with Clozapine
- (2010) Elaine Weiner et al. NEUROPSYCHOPHARMACOLOGY
- Effects of olanzapine and risperidone on lipid metabolism in chronic schizophrenic patients with long-term antipsychotic treatment: A randomized five month study
- (2010) Robert C. Smith et al. SCHIZOPHRENIA RESEARCH
- Effects of Olanzapine and Risperidone on Glucose Metabolism and Insulin Sensitivity in Chronic Schizophrenic Patients With Long-Term Antipsychotic Treatment
- (2009) Robert C. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- The role of histaminergic H1 and H3 receptors in food intake: A mechanism for atypical antipsychotic-induced weight gain?
- (2009) Chao Deng et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Effect of histaminergic manipulation on weight in obese adults: a randomized placebo controlled trial
- (2008) N Barak et al. INTERNATIONAL JOURNAL OF OBESITY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now